Harrow, Inc. (NASDAQ:HROW) Short Interest Down 9.5% in May

Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 4,980,000 shares, a decline of 9.5% from the April 30th total of 5,500,000 shares. Based on an average daily volume of 510,400 shares, the […]

Related Keywords

Markl Baum ,Craig Hallum ,Pricet Rowe Associates Inc ,Surface Ophthalmics Inc ,Pharmaceuticals Inc ,Nasdaq ,Opaleye Management Inc ,Harrow Inc ,Vanguard Group Inc ,Harrow Health Inc ,Eton Pharmaceuticals Inc ,Get Free Report ,Street Capital ,Opaleye Management ,Capital Management ,Financial Markets ,Stock Down ,Surface Ophthalmics ,Melt Pharmaceuticals ,Eton Pharmaceuticals ,Harrow Daily ,